European Multiple Myeloma Patients Face Unequal Access to Curative Treatments

At the European Hematology Association (EHA) 2026 Congress in Stockholm, speakers highlighted that while new drugs and treatment combinations make cure a realistic goal for many multiple myeloma (MM) patients in Europe, significant disparities in access to these treatments persis